| Objective: Evaluate randomized LowerHe-FroniMu points group and drug controlledgroup’s effectiveness and advantage for functional diarrhea and discuss clinical accupointsrule.Method: The study selected60functional diarrhea patients who met the criteria andrandomly devided into LowerHe-FroniMu points group and drug controlled group. Observeweek defecation, Bristol stool type, normal bowel movements day number, SAS and SDSscore.Result:1LowerHe-FroniMu points group’week bowel movement frequency is (10.18±3.24)while drug controlled group’s is(9.57±3.15), there is not significant differences(P=0.492).LowerHe-FroniMu points group’s8thweek follow-up period bowel movement frequency is(8.9±3.34)while the controlled group’s is (14.07±4.68), and there is significantdifferences(P=0.000).2LowerHe-FroniMu points group’s Bristol stool type mean is (4.71±0.69), and thecontrolled group’s mean is (4.68±0.76), there is not significant differences(P=0.749).LowerHe-FroniMu points group’s8thweek follow-up period Bristol stool type mean is (4.37±0.51)while the controlled group’s is (5.32±0.9), and there is significant differences(P=0.000).3LowerHe-FroniMu points group’s normal bowel movements day number is (2.55±2.05), and the controlled group’s day number is (2.48±2.08), there is not significantdifferences(P=0.886).Two groups’ baseline and4thweek’s normal bowel movements daynumber is (P=0.000)for Hemushuxue group and (P=0.000) for drug controlled group,there are significant differences in both groups’ effect (P<0.05). LowerHe-FroniMu pointsgroup’s8thweek follow-up period normal bowel movements day number is (P=0.000)whilethe controlled group’s is (P=0.005), and there is significant differences (P<0.05).4LowerHe-FroniMu points group’s baseline SAS score’s mean is (33.5±9.27),4thweek’s SAS score’s mean is(30.82±9.27), there are significant differences(P=0.044).Drugcontrolled group’s baseline SAS score’s mean is (34.08±6.41),4thweek’s SAS score’s mean is(33.83±6.96), there is not significant differences (P=0.761).5LowerHe-FroniMu points group’s baseline SDS score’s mean is (33.71±10.08),4thweek’s SAS score’s mean is(31.29±8.88), there is significant differences(P=0.153).Drugcontrolled group’s baseline SDS score’s mean is (32.63±5.93),4thweek’s SAS score’smean is(32.17±5.6), there is not significant differences (P=0.788).Conclusion: Two groups’ gender, age, disease duration, acupuncture expected value’scomparative analysis showed no significant difference (P>0.05), and in this case wecompared baseline,4th,8thafter treatment’s nomorl bowel movement day number showedsignificant differences (P<0.05)which means two groups’treatment are effective. But twogroups’ week defecation, Bristol stool type didn’t show significant differences(P>0.05)intreatment, and8thweek’s follow-up week defecation, Bristol stool type showed significantdifferences(P>0.05).The results did not show significant differences during the treatment,but LowerHe-FroniMu points group’s long-term effect is better then drug controlled group.The SAS score showed significant differences(P<0.05)in LowerHe-FroniMu points groupbut not in drug controlled group (P>0.05). Two group’s SDS score didn’t show significantdifference(sP>0.05), but the LowerHe-FroniMu points group’s improve scores is better thendrug controlled group’s which means accuponcture can improve mental, psychologicalfactors.Through this clinical observation, we proved that acupuncture’s advantage andeffectiveness for functional diarrhea, and explains Hemushucue method’s exact effect,objective, standardized, fixed acupoints, easy to operate in Liu Fu disease’s treatment, and itis suitable for widespread clinical. |